Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.
Lefèvre G, Bleuse S, Puyade M, Moulis G, Néel A, Abisror N, Baudet A, Bonnotte B, Dion J, Dossier A, Grall M, Lifermann F, Limal N, Lioger B, Machelart I, Mohr C, Outh R, Queyrel-Moranne V, Slama B, Tréfond L, Abou Chahla W, Ackerman F, Belfeki N, Berezne A, Blade JS, Bouderbala MA, Chebrek S, Cottin V, De Almeida S, De Masson A, Dezoteux F, Goulenok T, Jachiet V, Jouvray M, Latu I, Ledoult E, Leurs A, Lugosi M, Martin M, Melboucy-Belkhir S, Morati-Hafsaoui C, Quemeneur T, Rohmer J, Roy-Peaud F, Sanges S, Schleinitz N, Staumont-Salle D, Taillé C, Terriou L, Tieulie N, Koenga JDE, Schwarb L, Panel K, Kahn JE, Groh M; COHESion study group. Lefèvre G, et al. Among authors: taille c. Allergy. 2025 Jan 5. doi: 10.1111/all.16463. Online ahead of print. Allergy. 2025. PMID: 39757773
Lack of efficacy of tocilizumab in acute exacerbation of pulmonary fibrosis.
Franco G, Le Guen P, Le Brun M, Philippot Q, Dupin C, Debray MP, Bancal C, Taillé C, Borie R, Crestani B. Franco G, et al. Among authors: taille c. ERJ Open Res. 2024 Dec 2;10(6):00520-2024. doi: 10.1183/23120541.00520-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39624383 Free PMC article.
A RESPONSE to anti-IL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol.
Bakakos P, Alobid I, Constantinidis J, Hellings P, Pfaar O, Taillé C, Bañas-Conejero D, Kallinikou K, Howarth P, Schleich F. Bakakos P, et al. Among authors: taille c. J Allergy Clin Immunol Glob. 2024 Sep 17;4(1):100343. doi: 10.1016/j.jacig.2024.100343. eCollection 2025 Feb. J Allergy Clin Immunol Glob. 2024. PMID: 39554605 Free PMC article.
[Efficacy of biologics for severe asthma on allergic comorbidities].
Thibaut de Ménonville C, Barakat L, Laborier F, Le Brun M, Dupin C, Neukirch C, Taillé C. Thibaut de Ménonville C, et al. Among authors: taille c. Rev Mal Respir. 2024 Nov;41(9):669-679. doi: 10.1016/j.rmr.2024.08.004. Epub 2024 Oct 5. Rev Mal Respir. 2024. PMID: 39368873 Review. French.
Allergen Immunotherapy for the Prevention and Treatment of Asthma.
Batard T, Taillé C, Guilleminault L, Bozek A, Floch VB, Pfaar O, Canonica WG, Akdis C, Shamji MH, Mascarell L. Batard T, et al. Among authors: taille c. Clin Exp Allergy. 2024 Oct 4. doi: 10.1111/cea.14575. Online ahead of print. Clin Exp Allergy. 2024. PMID: 39363801 Review.
Cystic lung in sarcoidosis: Clinico-radiologic characteristic and evolution.
Franco G, Debray MP, Anzani N, Marruchella A, Cazes A, Le Guen P, Taillé C, Faverio P, Borie R, Luppi F, Crestani B. Franco G, et al. Among authors: taille c. Respirology. 2024 Dec;29(12):1067-1076. doi: 10.1111/resp.14823. Epub 2024 Aug 28. Respirology. 2024. PMID: 39197869 Free article.
Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial.
Valery S, Simon-Tillaux N, Devouassoux G, Bonniaud P, Beurnier A, Boudjemaa A, Chenivesse C, Bourdin A, Gauquelin L, Guillo S, Taillé C, Estellat C; RAMSES Study Group. Valery S, et al. Among authors: taille c. J Allergy Clin Immunol. 2024 Oct;154(4):922-932. doi: 10.1016/j.jaci.2024.05.023. Epub 2024 Jun 6. J Allergy Clin Immunol. 2024. PMID: 38848878 Clinical Trial.
284 results